United States · FDA National Drug Code directory
Marcaine Spinal
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0409-1761_ef77810e-d05c-4501-9512-10dbe0bc7f00
- Product NDC
- 0409-1761
- Form
- INJECTION, SOLUTION
- Composition / generic term
- Bupivacaine Hydrochloride in Dextrose
- Labeler
- Hospira, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20050519
- Source listing expiry
- 20271231
Source-listed ingredients
- BUPIVACAINE HYDROCHLORIDE — 7.5 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 2 CELLO PACK in 1 CARTON (0409-1761-10) / 5 AMPULE in 1 CELLO PACK (0409-1761-05) / 2 mL in 1 AMPULE (0409-1761-18) · 0409-1761-10
- 800 AMPULE in 1 CASE (0409-1761-62) / 2 mL in 1 AMPULE (0409-1761-18) · 0409-1761-62
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →